Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
FEBS Letters|September 5, 2020
Escherichia coli YegI is a novel Ser/Thr kinase lacking conserved motifs that localizes to the inner membraneKrithika Rajagopalan, Jonathan DworkinCurrent Medical Research and Opinion|October 6, 2018
Examining quality of care for individuals treated for mental health using the HEDIS mental health quality measuresDaisy Ng-Mak, Krithika RajagopalanEpilepsy & Behavior : E&B|September 4, 2019
Association between adherence to sodium channel blockers and patient-reported outcomes: Analysis of US survey data among patients with epilepsyKrithika Rajagopalan, Lulu K LeeCornea|October 27, 2004
The economic burden of dry eye: a conceptual framework and preliminary assessmentPrabashni Reddy, Oren Grad, Krithika RajagopalanAdvances in Therapy|June 30, 2026
Real-World Demographics, Clinical Characteristics, and Predictors of Persistence Among Males with Rett Syndrome Treated with TrofinetideKrithika Rajagopalan, Vinod Yakkala, Nazia RashidJournal of Medical Economics|June 5, 2023
Patients treated with pimavanserin or quetiapine for Parkinson's disease psychosis: analysis of health resource utilization patterns among Medicare beneficiariesKrithika Rajagopalan, Nazia Rashid, Dilesh DoshiJournal of Bacteriology|July 4, 2018
Identification and Biochemical Characterization of a Novel Protein Phosphatase 2C-Like Ser/Thr Phosphatase in Escherichia coliKrithika Rajagopalan, Jonathan Dworkin, Elizabeth NagleJournal of Comparative Effectiveness Research|December 15, 2023
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysisKrithika Rajagopalan, Nazia Rashid, Dilesh DoshiJournal of Clinical Psychopharmacology|July 21, 2006
Hospitalization risks in the treatment of schizophrenia: comparison of antipsychotic medicationsFrank Gianfrancesco, Krithika Rajagopalan, Ruey-hua WangClinicoeconomics and Outcomes Research : CEOR|November 15, 2018
Impact of antiepileptic-drug treatment burden on health-care-resource utilization and costsKrithika Rajagopalan, Sean D Candrilli, Mayank AjmeraPageof 11